Drug Eluting Balloons (DEBs): Discover Key Drivers that will Boost Growth

Synopsis of Growth Drivers with Market Forecast 2021-2025

The Global Drug Eluting Balloons (DEBs) Market is projected to grow by $ 543.81 million, accelerating at a CAGR of almost 12.41% till 2025. This research report delineates the growth drivers that will boost market growth along with a detailed analysis of the market segments, trends and challenges that are likely to impact market growth.

Request for our free sample report to get a glimpse into our exhaustive research and analysis: Download FREE Sample Report

Drug Eluting Balloons (DEBs) Market: Key Market Drivers

One of the key factors that will drive growth is the growing demand for cath labs. 39% of the market’s growth will originate from North America during the forecast period. The US and Canada are the key markets for drug eluting balloons in North America. The shift toward MI techniques will facilitate the drug eluting balloons market growth in North America over the forecast period. 

This research report provides a comprehensive analysis of this and all the other factors that will boost growth during the forecast period. In addition to market drivers, our research report also studies the latest trends and challenges that are likely to influence growth in the current market scenario. Our analysis is designed to empower clients with actionable insights that will help them leverage growth opportunities and formulate winning strategies to drive their business further.

Drug Eluting Balloons (DEBs) Market: Segments and Geographical Regions

This research report provides insights into the current market share of each segment along with growth projections for the next five years. In addition, the report also offers a detailed impact analysis of various trends, drivers, and challenges on each market segment along with insights into the way forward. These insights will equip clients with information that will help them design a growth strategy for their business and area of operation. Drug Eluting Balloons (DEBs) Market is segmented by Product (Peripheral DEBs and Coronary DEBs) and Geography (North America, Europe, Asia, and ROW). Market share growth by the peripheral DEBs segment has been significant in recent years and is expected to offer further growth opportunities during the forecast period. For more insights into this market:  Request our Free Sample Report

Drug Eluting Balloons (DEBs) Market: Vendor Analysis

The market is fragmented, and the growth of the players depends on several factors such as market conditions, government support, and industry development. Marke players must distinguish their product and service offerings through a clear and unique value proposition to prosper in this competitive market.  B. Braun Melsungen AG, Becton Dickinson and Co., BIOTRONIK SE & Co. KG, Boston Scientific Corp., Cardinal Health Inc., Cardionovum GmbH, Cook Medical LLC, Koninklijke Philips NV, Medtronic Plc, and Opto Circuits (India) Ltd. are some of the major market participants. The report offers a detailed analysis of each of the above-listed vendors and their product portfolio.

Technavio also offers custom research reports with detailed insights assessing the market from a global as well as regional perspective. This customized report will help clients keep up with new product launches in direct & indirect or related markets. It will also provide insights on upcoming developments along with pipeline analysis of vendor operations and the impact of government regulations.

For more insights on this market: Download a Free Sample Report

The report provides insights into the following FAQs:

1. What is the market CAGR?
   The market is accelerate at a CAGR of almost 12.41%.
    
2. What is the incremental growth of the market?
   The market is expected to grow by $ 543.81 mn through 2021-2025.
    
3. What is a key factor driving this market?
   Growing demand for cath labs will drive market growth over the forecast period.
    
4. What are the key regions covered in this market research report?
   North America, Europe, Asia, and ROW are the key regions featured in this research report.
    
5. Which is the leading geographic region for this market:
   39% growth will originate from North America
    
6. Who are the leading market vendors?
   The leading vendors in this market are B. Braun Melsungen AG, Becton Dickinson and Co., BIOTRONIK SE & Co. KG, Boston Scientific Corp., Cardinal Health Inc., Cardionovum GmbH, Cook Medical LLC, Koninklijke Philips NV, Medtronic Plc, and Opto Circuits (India) Ltd.
    
7. What are the market segments covered in this report?
   The market is segmented by Product (Peripheral DEBs and Coronary DEBs) and Geography (North America, Europe, Asia, and ROW)